113 related articles for article (PubMed ID: 36888972)
21. Antioxidant properties of N-(4-hydroxyphenyl)retinamide (fenretinide).
Takahashi N
Biol Pharm Bull; 2000 Feb; 23(2):222-5. PubMed ID: 10706389
[TBL] [Abstract][Full Text] [Related]
22. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
[TBL] [Abstract][Full Text] [Related]
24. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
[TBL] [Abstract][Full Text] [Related]
25. The oxidation states of DJ-1 dictate the cell fate in response to oxidative stress triggered by 4-hpr: autophagy or apoptosis?
Cao J; Ying M; Xie N; Lin G; Dong R; Zhang J; Yan H; Yang X; He Q; Yang B
Antioxid Redox Signal; 2014 Oct; 21(10):1443-59. PubMed ID: 24392637
[TBL] [Abstract][Full Text] [Related]
26. ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.
Cao J; Xu D; Wang D; Wu R; Zhang L; Zhu H; He Q; Yang B
Free Radic Biol Med; 2009 Sep; 47(5):536-47. PubMed ID: 19482076
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
28. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
29. Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
Chen NE; Maldonado NV; Khankaldyyan V; Shimada H; Song MM; Maurer BJ; Reynolds CP
Mol Cancer Ther; 2016 Nov; 15(11):2653-2664. PubMed ID: 27530131
[TBL] [Abstract][Full Text] [Related]
30. Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.
Illuzzi G; Bernacchioni C; Aureli M; Prioni S; Frera G; Donati C; Valsecchi M; Chigorno V; Bruni P; Sonnino S; Prinetti A
J Biol Chem; 2010 Jun; 285(24):18594-602. PubMed ID: 20404323
[TBL] [Abstract][Full Text] [Related]
31. A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.
Simeone AM; Ekmekcioglu S; Broemeling LD; Grimm EA; Tari AM
Mol Cancer Ther; 2002 Oct; 1(12):1009-17. PubMed ID: 12481423
[TBL] [Abstract][Full Text] [Related]
32. TMEM14A inhibits N-(4-hydroxyphenyl)retinamide-induced apoptosis through the stabilization of mitochondrial membrane potential.
Woo IS; Jin H; Kang ES; Kim HJ; Lee JH; Chang KC; Park JY; Choi WS; Seo HG
Cancer Lett; 2011 Oct; 309(2):190-8. PubMed ID: 21723035
[TBL] [Abstract][Full Text] [Related]
33. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
34. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis.
Shen JC; Wang TT; Chang S; Hursting SD
Mol Carcinog; 1999 Mar; 24(3):160-8. PubMed ID: 10204800
[TBL] [Abstract][Full Text] [Related]
36. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2.
Morales MC; Pérez-Yarza G; Rementería NN; Boyano MD; Apraiz A; Gómez-Muñoz A; Pérez-Andrés E; Asumendi A
Free Radic Res; 2007 May; 41(5):591-601. PubMed ID: 17454142
[TBL] [Abstract][Full Text] [Related]
37. p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.
Ganeshan VR; Schor NF
Cancer Chemother Pharmacol; 2014 Feb; 73(2):271-9. PubMed ID: 24253178
[TBL] [Abstract][Full Text] [Related]
38. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
39. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
Erdreich-Epstein A; Tran LB; Bowman NN; Wang H; Cabot MC; Durden DL; Vlckova J; Reynolds CP; Stins MF; Groshen S; Millard M
J Biol Chem; 2002 Dec; 277(51):49531-7. PubMed ID: 12388538
[TBL] [Abstract][Full Text] [Related]
40. Cell death induced by N-(4-hydroxyphenyl)retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma.
Davies M; Paterson IC; Ganapathy A; Prime SS
Int J Cancer; 2006 Dec; 119(12):2803-11. PubMed ID: 17044020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
